Know Cancer

or
forgot password

Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)


N/A
19 Years
N/A
Open (Enrolling)
Both
HIV, Osteoporosis

Thank you

Trial Information

Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)


Inclusion Criteria:



- treatment naïve patients seen in the 1917 Clinic between January 1, 2000 and May 1,
2010

- currently under care at the time of the initiation of the study (>1 clinic visit in
the past 12 months)

Exclusion Criteria:

- history of chronic renal failure (estimated GFR <30ml/min)

- known diagnosis of a metabolic bone disease (i.e. osteoporosis, primary
hyperparathyroidism, Paget Disease, Osteogenesis Imperfecta)

- multiple myeloma, cancer, untreated thyroid disease, or inflammatory bowel disease,
or persons currently treated with or plans to begin an osteoporosis-specific
medication (including estrogen)

- treatment with oral glucocorticoids and anticonvulsants

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Cross-Sectional

Outcome Measure:

Bone Mineral Density

Outcome Description:

Change in BMD after 1 year

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Amy H. Warriner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Alabama at Birmingham

Authority:

United States: Institutional Review Board

Study ID:

HIVBone_K12

NCT ID:

NCT01591252

Start Date:

April 2012

Completion Date:

September 2013

Related Keywords:

  • HIV
  • Osteoporosis
  • HIV
  • Bone mineral density
  • bone turnover
  • fracture
  • inflammation
  • Fractures, Bone
  • Osteoporosis

Name

Location

UABBirmingham, Alabama  35294